ATMA CENA Events

In this webinar, we will discuss what current North American legislative moves mean for access and the future, as well as review the current legal, above-ground pathways that already exist in Canada. The current pathways are not always simple to navigate. Canadian clinicians and researchers can access regulatory approval to offer psychedelic-assisted therapy through clinical trials and established treatment programs. Access is possible, happening, and growing.

You’ve heard about psychedelic therapy. But have you heard about psycholytic psychedelic therapy? It’s not about going deep into an altered state — it’s about going just far enough. A psycholytic (lower-dose) approach uses psychedelics to create a gentle, non-ordinary state of mind. You stay in your body, and with a therapist by your side, the usual walls come down just enough to make real therapeutic work possible.

Join us for a virtual office hours session — an informal Q&A with the ATMA CENA team. Whether you’re exploring psychedelic-assisted therapy (PAT) training for the first time or ready to take the next step, this is your chance to ask real questions and learn about our introductory and advanced pathway options, hands-on experiential training, and what to expect from our curriculum.

Join us for a virtual office hours session — an informal Q&A with the ATMA CENA team. Whether you’re exploring psychedelic-assisted therapy (PAT) training for the first time or ready to take the next step, this is your chance to ask real questions and learn about our introductory and advanced pathway options, hands-on experiential training, and what to expect from our curriculum.